SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Edwards Lifesciences Corporation Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$48.78M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.46% | 25.22K shares | -4.95M | $82.63 | 590.45K |
| Q2 2022 | share | Increase | +79.90% | 251.03K shares | 16.76M | $95.09 | 565.23K |
| Q1 2022 | share | Decrease | -42.14% | -228.79K shares | -33.97M | $117.72 | 314.19K |
| Q4 2021 | share | Decrease | -0.69% | -3.76K shares | 9.06M | $130.68 | 542.98K |
| Q3 2021 | share | Increase | +5.15% | 26.79K shares | 8.04M | $113.21 | 546.74K |
| Q2 2021 | share | Decrease | -9.39% | -53.91K shares | 5.85M | $103.57 | 519.94K |
| Q1 2021 | share | Decrease | -26.45% | -206.35K shares | -23.18M | $83.64 | 573.85K |
| Q4 2020 | share | Decrease | -3.40% | -27.45K shares | 6.71M | $91.23 | 780.21K |
| Q3 2020 | share | Decrease | -0.02% | -175 shares | 8.63M | $79.82 | 807.66K |
| Q2 2020 | share | Decrease | -9.57% | -85.52K shares | -339K | $69.11 | 807.84K |
| Q1 2020 | share | Increase | +7.44% | 61.85K shares | -8.49M | $62.87 | 893.36K |
| Q4 2019 | share | Increase | +330.72% | 638.46K shares | 50.51M | $77.76 | 831.51K |
| Q3 2019 | share | Increase | +54.86% | 68.39K shares | 6.47M | $73.3 | 193.05K |
| Q2 2019 | share | Increase | +4.53% | 5.40K shares | 71K | $61.58 | 124.65K |
| Q1 2019 | share | Decrease | -1.87% | -2.27K shares | 1.40M | $63.78 | 119.25K |
| Q4 2018 | share | Increase | +13.05% | 14.02K shares | -34K | $51.06 | 121.53K |
| Q3 2018 | share | Decrease | -3.50% | -3.9K shares | 833K | $58.03 | 107.50K |
| Q2 2018 | share | Increase | +42.87% | 33.42K shares | 1.78M | $48.52 | 111.40K |
| Q1 2018 | share | Decrease | -32.83% | -38.10K shares | -735K | $46.51 | 77.97K |
| Q4 2017 | share | Decrease | -59.15% | -168.05K shares | -5.99M | $37.57 | 116.07K |
| Q3 2017 | share | Increase | +163.74% | 176.4K shares | 6.10M | $36.44 | 284.13K |
| Q2 2017 | share | Increase | +2.57% | 2.7K shares | 953K | $39.41 | 107.73K |
| Q1 2017 | share | Decrease | -71.13% | -258.76K shares | -8.07M | $31.36 | 105.03K |
| Q4 2016 | share | Decrease | -67.05% | -740.29K shares | -33.00M | $31.23 | 363.79K |
| Q3 2016 | share | Decrease | -8.43% | -101.7K shares | 4.28M | $40.19 | 1.10M |
| Q2 2016 | share | Increase | +0.27% | 3.3K shares | 4.72M | $33.24 | 1.20M |
| Q1 2016 | share | Increase | 0.00% | 1.20M shares | 35.35M | $29.4 | 1.20M |